Related Experiment Video
Updated: Jun 13, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Mitochondrial dynamics as a potential therapeutic target in acute myeloid leukemia
Mariko Kinoshita1, Yusuke Saito2, Kento Otani3
1Division of Pediatrics, Faculty of Medicine, University of Miyazaki, 5200, Kihara, Kiyotake, Miyazaki, 889-1692, Japan. mariko_kinoshita@med.miyazaki-u.ac.jp.
Abstract:
Acute myeloid leukemia (AML) cells are highly dependent on oxidative phosphorylation and the mitochondrial dynamics regulated by fusion-related genes MFN1, MFN2, and OPA1 and fission-related genes DNM1L and MFF. An analysis of previously published gene expression datasets showed that high expression of MFF was significantly associated with poor prognosis in patients with AML. Based on this finding, we investigated the impact of mitochondrial dynamics in AML. Transduction of shRNA against fission-related genes, DNM1L and MFF, inhibited growth and increased the mitochondrial area in AML cell lines. Extracellular flux analysis showed that deletion of mitochondrial dynamic regulators reduced mitochondrial respiration without significantly affecting glycolysis, except in shDNM1L-transfected cells. Immunodeficient NOG mice transplanted with DNM1L- or MFF-knockdown AML cells survived significantly longer than controls. Treatment of AML cell lines with Mdivi-1, which inhibits the DRP1 encoded by DNM1L, inhibited cell proliferation and oxidative phosphorylation. Our results show that mitochondrial dynamics play an important role in AML, and provide novel biological insights. The inhibition of mitochondrial dynamics induces unique mitochondrial alterations, which may be explored as a potential therapeutic target in AML.
Insights
Targeting mitochondrial dynamics, essential for acute myeloid leukemia (AML) cell growth, offers a promising therapeutic strategy. Inhibiting fission-related genes like MFF and DNM1L significantly impaired AML cell proliferation and improved survival in mice.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Acute myeloid leukemia (AML) cells rely heavily on oxidative phosphorylation.
- Mitochondrial dynamics, regulated by fusion (MFN1, MFN2, OPA1) and fission (DNM1L, MFF) genes, are critical for AML cell function.
- High MFF expression correlates with poor prognosis in AML patients.
Purpose of the Study:
- To investigate the role of mitochondrial dynamics in AML.
- To explore the therapeutic potential of targeting mitochondrial fission in AML.
Main Methods:
- Gene expression analysis of published datasets.
- shRNA-mediated knockdown of DNM1L and MFF in AML cell lines.
- Extracellular flux analysis to assess cellular respiration and glycolysis.
- In vivo studies using immunodeficient NOG mice.
- Pharmacological inhibition of DNM1L using Mdivi-1.
Main Results:
- Knockdown of DNM1L or MFF inhibited AML cell growth and increased mitochondrial area.
- Mitochondrial dynamic regulator deletion reduced oxidative phosphorylation without significantly impacting glycolysis (except in shDNM1L cells).
- DNM1L or MFF knockdown in AML cells led to significantly longer survival in NOG mice.
- Mdivi-1 treatment inhibited AML cell proliferation and oxidative phosphorylation.
Conclusions:
- Mitochondrial dynamics are crucial for AML pathogenesis.
- Inhibition of mitochondrial dynamics induces unique mitochondrial alterations in AML.
- Targeting mitochondrial dynamics presents a novel therapeutic strategy for AML.
Related Concept Videos
Mitochondrial Membranes
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Destabilization of Microtubules

